Pay in 4 interest-free payments of $7.06 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
All participants had a diagnosis of ASD established with DSM-IV-TR or DSM-5 and validated with ADOS-2 and/or ADI-R, while individuals with neurological or psychiatric comorbidities, recent probiotic or oxytocin use, or unstable medications were excluded
25 (18 Suppl.), LBA5528 (2007)
Consult a licensed healthcare professional before making any medical or health-related decisions.
Molecular Neurobiology 61 (6): 34903502
US$ 28.70
US$ 29.39
US$ 24.37
US$ 4074.00
Sold : Login>>
